Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$505.16 USD

505.16
2,142,054

-6.10 (-1.19%)

Updated Oct 2, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

West Pharmaceutical (WST) Q2 Earnings Beat, HVP Drives Sales

West Pharmaceutical's (WST) second-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.

Chemed (CHE) Q2 Earnings Miss Estimates, '23 EPS View Down

Chemed's (CHE) second-quarter 2023 performance reflects strength in the VITAS segment, while expenses weigh on margins.

Align Technology (ALGN) Q2 Earnings Beat, Gross Margin Up

Align Technology (ALGN) delivers impressive earnings in the second quarter of 2023.

Teladoc Health (TDOC) Q2 Earnings Top Estimates on Lower Expenses

Teladoc Health's (TDOC) Q2 results reflect improving access fees and other revenues coupled with lower expenses.

Merit Medical (MMSI) Q2 Earnings & Revenues Beat Estimates

Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the second quarter.

Universal Health (UHS) Q2 Earnings Beat, Boosts '23 EPS View

Universal Health's (UHS) Q2 results indicate improved patient admissions and solid segmental performance. Management currently expects adjusted EPS within $9.85-$10.50 for 2023.

Thermo Fisher (TMO) Q2 Earnings Miss Estimates, Margins Down

Challenging macroeconomic conditions and slowdown in activities in China impede Thermo Fisher's (TMO) Q2 revenues.

Quest Diagnostics (DGX) Q2 Earnings Beat Estimates, FY View Up

Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023.

NextGen (NXGN) Q1 Earnings Top Estimates, Revenues Surge Y/Y

NextGen's (NXGN) first-quarter fiscal 2024 results reflect strength in its revenue sources.

ELV or DOCS: Which Is the Better Value Stock Right Now?

ELV vs. DOCS: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health

Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Alphabet, Procter & Gamble & Linde

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), The Procter & Gamble Company (PG) and Linde plc (LIN).

Company News for Jul 20, 2023

Companies In The News Are: MTB, ELV, BKR, NTRS.

Elevance Health (ELV) Beats on Q2 Earnings, Ups '23 Profit View

Elevance Health's (ELV) Q2 results benefit from an expanding customer base and solid pharmacy product revenues. Adjusted net income is expected to be more than $32.85 per share for 2023.

Elevance Health (ELV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates

Elevance Health (ELV) delivered earnings and revenue surprises of 2.49% and 4.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Carelon Growth Aid Elevance Health's (ELV) Q2 Earnings?

Elevance Health's (ELV) second-quarter results are likely to reflect rising memberships in Medicare Advantage, Medicaid, Vision and Dental Administration businesses.

Elevance Health (ELV) Earnings Expected to Grow: Should You Buy?

Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights Linde, Elevance Health, Lam Research, KLA and Johnson Controls

Linde, Elevance Health, Lam Research, KLA and Johnson Controls are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Linde, Elevance Health & Lam Research

Today's Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Elevance Health, Inc. (ELV) and Lam Research Corporation (LRCX).

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Sheraz Mian headshot

Top Stock Reports for Meta Platforms, Boeing & IBM

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), The Boeing Company (BA) and International Business Machines Corporation (IBM).

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Mark Vickery headshot

Top Research Reports for Tesla, TotalEnergies & Intuitive Surgical

Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), TotalEnergies SE (TTE) and Intuitive Surgical, Inc. (ISRG).